Labcorp Holdings INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
Vanguard Capital Management disclosed a beneficial ownership of 7.52% in Labcorp Holdings Inc. as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership in Labcorp Holdings Inc. following an internal realignment.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.6% beneficial ownership stake in Labcorp Holdings Inc. as of March 31, 2025.